Compare AGNC & BAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AGNC | BAX |
|---|---|---|
| Founded | 2008 | 1931 |
| Country | United States | United States |
| Employees | 54 | N/A |
| Industry | Real Estate Investment Trusts | Medical/Dental Instruments |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 11.5B | 10.2B |
| IPO Year | N/A | 1994 |
| Metric | AGNC | BAX |
|---|---|---|
| Price | $10.22 | $17.41 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 12 | 9 |
| Target Price | $11.03 | ★ $22.13 |
| AVG Volume (30 Days) | ★ 16.9M | 9.5M |
| Earning Date | 01-01-0001 | 05-14-2026 |
| Dividend Yield | ★ 13.86% | 0.22% |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $11,244,000,000.00 |
| Revenue This Year | N/A | $1.90 |
| Revenue Next Year | $0.51 | $2.09 |
| P/E Ratio | $7.69 | ★ N/A |
| Revenue Growth | N/A | ★ 5.72 |
| 52 Week Low | $7.85 | $17.07 |
| 52 Week High | $12.19 | $35.03 |
| Indicator | AGNC | BAX |
|---|---|---|
| Relative Strength Index (RSI) | 27.17 | 35.18 |
| Support Level | $9.85 | N/A |
| Resistance Level | $10.32 | $19.31 |
| Average True Range (ATR) | 0.24 | 0.79 |
| MACD | -0.09 | -0.26 |
| Stochastic Oscillator | 0.43 | 8.98 |
AGNC Investment Corp is a real estate investment trust that invests in agency residential mortgage-backed securities. The firm's asset portfolio is comprised of residential mortgage pass-through securities and collateralized mortgage obligations for which the principal and interest payments are guaranteed by a U.S. Government-sponsored enterprise, such as the Federal National Mortgage Association and the Federal Home Loan Mortgage Corporation, or by a U.S. Government agency, such as the Government National Mortgage Association. It also invests in other types of mortgage and mortgage-related residential and commercial mortgage-backed securities or other investments in or related to, the housing, mortgage, or real estate markets.
Baxter offers a variety of medical supplies and equipment to providers. From its legacy operations, Baxter sells injectable therapies for use in care settings, including IV pumps, administrative sets, and solutions; nutritional products; and surgical sealants and hemostatic agents. Baxter expanded its portfolio of hospital-focused offerings by acquiring Hillrom in late 2021, which added basic equipment like hospital beds, operating room equipment, and patient monitoring tools to the portfolio. Baxter also sold its kidney care tools in early 2025.